Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Urology Open Science|September 1, 2021
Immunomodulation-A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?Björn Wullt, Daniel S C Butler, Ines Ambite, et al.
Nature Communications|August 28, 2024
Structural basis of frizzled 7 activation and allosteric regulationJulien Bous, Julia Kinsolving, Lukas Grätz, et al.
Nature Communications|December 14, 2025
In silico docking yields small molecule negative allosteric modulators targeting the core of Frizzled 7Magdalena M Scharf, Julia Kinsolving, Lukas Grätz, et al.
British Journal of Pharmacology|April 13, 2023
NanoBiT- and NanoBiT/BRET-based assays allow the analysis of binding kinetics of Wnt-3a to endogenous Frizzled 7 in a colorectal cancer modelLukas Grätz, Joanna J Sajkowska-Kozielewicz, Janine Wesslowski, et al.
Cell Reports|February 3, 2024
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7Julia Kinsolving, Julien Bous, Pawel Kozielewicz, et al.
Journal of Medicinal Chemistry|December 13, 2024
A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase InhibitorJulia Kinsolving, Lukas Grätz, Jan Hendrik Voss, et al.
The Journal of Biological Chemistry|September 24, 2025
SAG1.3-derived Frizzled-targeting small-molecule compoundsLukas Grätz, Ainoleena Turku, Pawel Kozielewicz, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 1